Facing the problem of antibiotic resistances, a therapeutical inhibition of the interplay between streptococci and plasminogen might constitute an alternative approach to significantly reduce bacterial cell adherence, immune evasion, and tissue degradation and would provide a promising strategy for combating severe streptococcal infections. This evidence concerns the gene PLG and streptococcal infection.